US Edition
Alex Keeton named head of the Biosimilars Council, AAM SVP of policy
Summary by drugstorenews.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Alex Keeton named head of the Biosimilars Council, SVP of Policy
WASHINGTON — The Association for Accessible Medicines has named Alex Keeton as the Executive Director of the Biosimilars Council and Senior Vice of Policy for AAM. Keeton was most recently Vice President of Pharmacy Care Services at UnitedHealth Group and previously served in senior roles at the Biotechnology Innovation Organization and America’s Health Insurance Plans.Alex Keeton“Alex brings a wealth of experience to the Biosimilars Council and…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
